retatrutide pros and cons the weight loss drug everyone is asking about isn't FDA approved yet. retatrutide. triple agonist. GLP-1 + GIP + glucagon. phase 3 data showing ~29% body weight reduction. people are already sourcing retatrutide benefits clinical trial retatrutide

The average American consumes about 15 grams of fiber daily

Despite ongoing clinical characterization of these structural modifications, the evidence is clear that these intracellular cascades translate into robust systemic improvements that have redefined the standard of care (Lee et al., 2025) is supported by high-quality evidence from trials such as LEADER and SUSTAIN-6 (Marso et al., 2017)

But I do think it is something that we should be looking at because there are people who have insulin dysregulation even though they're not obese and they're not overweight

Our Illinois GLP-1 program includes regular virtual check-ins with our medical team to track your progress, manage any side effects, and adjust your personalized plan

Patients (n = 9,340) were randomised to liraglutide or placebo for 3.5 and up to five years and showed durable effects on glycated haemoglobin and on body weight

The escalation schedule exists for a reason